Combination treatment of dipeptidyl peptidase IV inhibitor and angiotensin-II type 1 receptor blocker attenuates progression of nonalcoholic steatohepatitis in rats

被引：0
|
作者：
Okura, Yasushi [1 ]
Namisaki, Tadashi [1 ]
Kaji, Kosuke [1 ]
Noguchi, Ryuichi [1 ]
Takeda, Kosuke [1 ]
Moriya, Kei [1 ]
Kitade, Mitsuteru [1 ]
Nishimura, Norihisa [1 ]
Seki, Kenichiro [1 ]
Sato, Shinya [1 ]
Takaya, Hiroaki [1 ]
Kawaratani, Hideto [1 ]
Sawada, Yasuhiko [1 ]
Shimozato, Naotaka [1 ]
Nakanishi, Keisuke [1 ]
Yoshiji, Hitoshi [1 ]
机构：
[1] Nara Med Univ, Dept Internal Med 3, Kashihara, Nara, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1610
引用
收藏
页码：798A / 798A
页数：1
相关论文
共 50 条
  • [1] IMPACT OF THE COMBINATION OF DIPEPTIDYL PEPTIDASE IV INHIBITOR AND ANGIOTENSIN-II TYPE 1 RECEPTOR BLOCKER ON HEPATOCARCINOGENESIS IN A RAT MODEL OF NONALCOHOLIC STEATOHEPATITIS
    Okura, Y.
    Namisaki, T.
    Noguchi, R.
    Takeda, K.
    Moriya, K.
    Kitade, M.
    Nishimura, N.
    Sato, S.
    Sawada, Y.
    Kawaratani, H.
    Seki, K.
    Kaji, K.
    Yoshiji, H.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S582 - S582
  • [2] Angiotensin II type 1 receptor blocker attenuates the progression of nonalcoholic steatohepatitis (NASH)
    Hirose, A.
    Ono, M.
    Saibara, T.
    Nozaki, Y.
    Takahashi, M.
    Iwasaki, S.
    Oben, J. A.
    Onishi, S.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S348 - S349
  • [3] Combination treatment of angiotensin II type I receptor blocker and new oral iron chelator attenuates progression of nonalcoholic steatohepatitis in rats
    Kaji, Kosuke
    Yoshiji, Hitoshi
    Kitade, Mitsuteru
    Ikenaka, Yasuhide
    Noguchi, Ryuichi
    Shirai, Yusaku
    Aihara, Yosuke
    Namisaki, Tadashi
    Yoshii, Junichi
    Yanase, Koji
    Tsujimoto, Tatsuhiro
    Kawaratani, Hideto
    Fukui, Hiroshi
    AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2011, 300 (06): : G1094 - G1104
  • [4] Combined treatment with dipeptidyl peptidase-4 inhibitor (sitagliptin) and angiotensin-II type 1 receptor blocker (losartan) suppresses progression in a non-diabetic rat model of steatohepatitis
    Okura, Yasushi
    Namisaki, Tadashi
    Moriya, Kei
    Kitade, Mitsuteru
    Takeda, Kosuke
    Kaji, Kosuke
    Noguchi, Ryuichi
    Nishimura, Norihisa
    Seki, Kenichiro
    Kawaratani, Hideto
    Takaya, Hiroaki
    Sato, Shinya
    Sawada, Yasuhiko
    Shimozato, Naotaka
    Furukawa, Masanori
    Nakanishi, Keisuke
    Saikawa, Soichiro
    Kubo, Takuya
    Asada, Kiyoshi
    Yoshiji, Hitoshi
    HEPATOLOGY RESEARCH, 2017, 47 (12) : 1317 - 1328
  • [5] Telmisartan, An Angiotensin II Type 1 Receptor Blocker, Controls Progress of Nonalcoholic Steatohepatitis in Rats
    Koji Fujita
    Masato Yoneda
    Koichiro Wada
    Hironori Mawatari
    Hirokazu Takahashi
    Hiroyuki Kirikoshi
    Masahiko Inamori
    Yuichi Nozaki
    Shiro Maeyama
    Satoru Saito
    Tomoyuki Iwasaki
    Yasuo Terauchi
    Atsushi Nakajima
    Digestive Diseases and Sciences, 2007, 52 : 3455 - 3464
  • [6] Telmisartan, an angiotensin II type 1 receptor blocker, controls progress of nonalcoholic steatohepatitis in rats
    Fujita, Koji
    Yoneda, Masato
    Wada, Koichiro
    Mawatari, Hironori
    Takahashi, Hirokazu
    Kirikoshi, Hiroyuki
    Inamori, Masahiko
    Nozaki, Yuichi
    Maeyama, Shiro
    Saito, Satoru
    Iwasaki, Tomoyuki
    Terauchi, Yasuo
    Nakajima, Atsushi
    DIGESTIVE DISEASES AND SCIENCES, 2007, 52 (12) : 3455 - 3464
  • [7] Combination of Dipeptidyl Peptidase-IV Inhibitor, Vildagliptin and Angiotensin-II Receptor Blocker, Varsartan Ameliorates Both Insulin Insufficiency and Insulin Resistance in Mouse Models of Type 2 Diabetes
    Miyagawa, Katsutoshi
    Kondo, Tatsuya
    Matsuyama, Rina
    Goto, Rieko
    Kawashima, Junji
    Motoshima, Hiroyuki
    Araki, Eiichi
    DIABETES, 2012, 61 : A482 - A482
  • [8] Impact of the combination of Farnesoid X receptor agonist and angiotensin-II type1 receptor blocker on hepatic fibrogenesis in the rat model of nonalcoholic steatohepatitis
    Namisaki, Tadashi
    Okura, Yasushi
    Sato, Shinya
    Kitade, Mitsuteru
    Kaji, Kosuke
    Nishimura, Norihisa
    Moriya, Kei
    Takeda, Kosuke
    Seki, Kenichiro
    Shimozato, Naotaka
    Noguchi, Ryuichi
    Kawaratani, Hideto
    Sawada, Yasuhiko
    Yoshiji, Hitoshi
    HEPATOLOGY, 2016, 64 : 828A - 828A
  • [9] Effective Combination Therapy of Angiotensin-II Receptor Blocker and Rifaximin for Hepatic Fibrosis in Rat Model of Nonalcoholic Steatohepatitis
    Fujinaga, Yukihisa
    Kawaratani, Hideto
    Kaya, Daisuke
    Tsuji, Yuki
    Ozutsumi, Takahiro
    Furukawa, Masanori
    Kitagawa, Koh
    Sato, Shinya
    Nishimura, Norihisa
    Sawada, Yasuhiko
    Takaya, Hiroaki
    Kaji, Kosuke
    Shimozato, Naotaka
    Moriya, Kei
    Namisaki, Tadashi
    Akahane, Takemi
    Mitoro, Akira
    Yoshiji, Hitoshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (15) : 1 - 15
  • [10] Angiotensin II type I receptor antagonist attenuates hepatic carcinogenesis in nonalcoholic steatohepatitis in rats
    Tamaki, Yosui
    Nakade, Yukiomi
    Sudo, Ryuji
    Chisaka, Kenji
    Kitano, Yohei
    Okada, Mitsuyoshi
    Matsumoto, Kakuya
    Aso, Kazunobu
    Makino, Yuichi
    Haneda, Masakazu
    GASTROENTEROLOGY, 2008, 134 (04) : A769 - A770
12345